Robert Lorne Hopfner's Net Worth

$145 Million

Estimate Recalculated Jul 17, 2024 03:05PM EST

Who is Robert Lorne Hopfner?

Robert Lorne Hopfner has an estimated net worth of $145 Million. This is based on reported shares across multiple companies, which include Vaxcyte, Inc., Inozyme Pharma, Inc., Rallybio Corp, and HYPERION THERAPEUTICS INC.

SEC CIK

Robert Lorne Hopfner's CIK is 0001551966

Past Insider Trading and Trends

2023 was Robert Lorne Hopfner's most active year for acquiring shares with 9 total transactions. Robert Lorne Hopfner's most active month to acquire stocks was the month of May. 2021 was Robert Lorne Hopfner's most active year for disposing of shares, totalling 42 transactions. Robert Lorne Hopfner's most active month to dispose stocks was the month of December. 2021 saw Robert Lorne Hopfner paying a total of $7,499,999.00 for 2,294,118 shares, this is the most they've acquired in one year. In 2021 Robert Lorne Hopfner cashed out on 11,621,742 shares for a total of $22,042,024.24, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Vaxcyte, Inc. (PCVX) Snapshot price: $73.92

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 2
Form 4
-21.23%
-378.70K
$27.34
-$10,355,466.25
1.41M
Scheduled
Feb 8 - Feb 10
Form 4
-0.94%
-17.00K
$25.12
-$427,066.50
1.78M
Scheduled
Feb 2 - Feb 3
Form 4
-0.11%
-2.00K
$25.07
-$50,140.00
1.8M
Scheduled
Jan 28
Form 4
-2.97%
-55.25K
$25.62
-$1,415,845.34
1.8M
Scheduled
Jan 25 - Jan 27
Form 4
-1.62%
-30.53K
$25.28
-$771,723.38
1.86M
Scheduled
Jan 20 - Jan 22
Form 4
-4.60%
-91.11K
$25.71
-$2,342,558.10
1.89M
Scheduled
Jan 14 - Jan 19
Form 4
-4.69%
-97.34K
$26.29
-$2,558,948.07
1.98M
Scheduled
Jan 11 - Jan 13
Form 4
-6.55%
-145.61K
$28.30
-$4,120,276.60
2.08M
Scheduled
Jan 6 - Jan 8
Form 4
∞
2.22M
$16.00
—
2.22M
Jun 16
Form 4
—
0
—
—
0
Jun 11
Form 3
—
0
—
—
0
No matching records found

Inozyme Pharma, Inc. (INZY) Snapshot price: $5.38

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 18
Form 4
+22.76%
833.33K
$4.80
$3,999,998.40
4.49M
Aug 1
Form 4
—
0
—
—
0
Jun 13
Form 4
+13.94%
447.93K
$6.36
$2,849,997.90
3.66M
May 11 - May 12
Form 4
+12.01%
344.59K
$4.54
$1,563,724.04
3.21M
Mar 29
Form 4
+7.81%
207.84K
$4.05
$841,063.32
2.87M
Mar 27 - Mar 28
Form 4
—
0
—
—
0
Jun 10
Form 4
+67.25%
1.07M
$3.69
$3,948,300.00
2.66M
Apr 19
Form 4
—
0
—
—
0
Jun 23
Form 4
∞
1.59M
$16.00
—
1.59M
Jul 28
Form 4
—
0
—
—
0
Jul 23
Form 3
—
0
—
—
0
No matching records found

Rallybio Corp (RLYB) Snapshot price: $1.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Jan 3
Form 4
+134.36%
2.27M
$13.00
$7,499,999.00
3.96M
Jul 28 - Aug 2
Form 3
—
0
—
—
0
No matching records found

HYPERION THERAPEUTICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found